DDX6 | DEAD (Asp-Glu-Ala-Asp) box helicase 6 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DHX16 | DEAH (Asp-Glu-Ala-His) box polypeptide 16 | Enzymes
| | | | | Expressed in all |
DHX30 | DEAH (Asp-Glu-Ala-His) box helicase 30 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
DHX36 | DEAH (Asp-Glu-Ala-His) box polypeptide 36 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
DHX9 | DEAH (Asp-Glu-Ala-His) box helicase 9 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
DNM1L | Dynamin 1-like | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
DNM2 | Dynamin 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP8 | Dipeptidyl-peptidase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
DUSP10 | Dual specificity phosphatase 10 | Enzymes
| | | | | Expressed in all |
DUSP16 | Dual specificity phosphatase 16 | Enzymes
| | | | | Expressed in all |
DUT | Deoxyuridine triphosphatase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
EIF4A3 | Eukaryotic translation initiation factor 4A3 | Disease related genes Enzymes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
ENOPH1 | Enolase-phosphatase 1 | Enzymes
| | | | | Expressed in all |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
EPHX2 | Epoxide hydrolase 2, cytoplasmic | Enzymes Plasma proteins
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ESD | Esterase D | Enzymes Plasma proteins
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GTF2F2 | General transcription factor IIF, polypeptide 2, 30kDa | Enzymes
| | | | | Expressed in all |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HDAC1 | Histone deacetylase 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets
| | | | | Expressed in all |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
HDAC8 | Histone deacetylase 8 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ITPA | Inosine triphosphatase (nucleoside triphosphate pyrophosphatase) | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
KATNA1 | Katanin p60 (ATPase containing) subunit A 1 | Enzymes
| | | | | Expressed in all |
KYNU | Kynureninase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
LAP3 | Leucine aminopeptidase 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
LHPP | Phospholysine phosphohistidine inorganic pyrophosphate phosphatase | Enzymes
| | | | | Expressed in all |
LPIN2 | Lipin 2 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MAN1A2 | Mannosidase, alpha, class 1A, member 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MAN2A1 | Mannosidase, alpha, class 2A, member 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MAN2B1 | Mannosidase, alpha, class 2B, member 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
MANEA | Mannosidase, endo-alpha | Enzymes Predicted membrane proteins
| | | | | Mixed |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MCM2 | Minichromosome maintenance complex component 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM3 | Minichromosome maintenance complex component 3 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM4 | Minichromosome maintenance complex component 4 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
MCM5 | Minichromosome maintenance complex component 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM6 | Minichromosome maintenance complex component 6 | Enzymes Plasma proteins
| | | | | Expressed in all |
MCM7 | Minichromosome maintenance complex component 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | Enzymes Predicted secreted proteins
| | | | | Expressed in all |